Emerging cytokines and cytokine signalling molecules as ...

30.06.2014 • Views

Share Embed Flag

Emerging cytokines and cytokine signalling molecules as ...

Emerging cytokines and cytokine signalling molecules as ...

DOWNLOAD ePAPER

rheumatology.org.uk

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Koebner phenomenon

1
2
3
4
5
6
7
8
9
10
11
12
13
15
16
17
18
19
20
21
22
23
24
25
26
27

Final Programme - The British Society for Rheumatology

Management of polymyalgia rheumatica - The British Society for ...

December 2009 - The British Society for Rheumatology

Guidelines for the treatment of psoriatic arthritis with biologics

BSRBR|Newsletter - The British Society for Rheumatology

Programme - The British Society for Rheumatology

PMR Classification Criteria

BSR & BHPR Guidelines on the use of Rituximab in Rheumatoid ...

Final Programme - The British Society for Rheumatology

Final Programme - The British Society for Rheumatology

Raynaud's phenomenon, digital ulcers and critical digital ischaemia

Dual specificity phosphatase 1 is a crucial negative

Foot outcomes from the Chingford cohort study of

Risk of septic arthritis in patients with rheumatoid - The British ...

Koebner phenomenon

McGonagle D, JEADV 2009

Page 1 and 2: Emerging cytokines and cytokine sig
Page 3 and 4: Regulation of immune responses pro-
Page 5: Tissue cells Chemokines: MCP-1 IL-8
Page 9 and 10: Anti-cytokine therapies developed f
Page 11 and 12: IL-12/IL-23p40 Bell et al, Nat Rev
Page 13: IL-17 and TNF act synergistically +
Page 16 and 17: IL-17 stimulates Psoriasis-Keratino
Page 18 and 19: IL-1F9 protein expression in kertin
Page 20 and 21: IL-36 Schulze-Tanzil et al.
Page 22 and 23: Cytokine receptors signal directly
Page 24 and 25: Highly selective kinase inhibitors
Page 26 and 27: Outlook • microRNA • Epigenetic